"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente - Sacramento conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 114 clinical trials were completed, i.e. on average, 148.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 43 clinical trials were completed. i.e. 716.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente - Sacramento" #1 sponsor was "National Cancer Institute (NCI)" with 60 trials, followed by "SWOG Cancer Research Network" with 34 trials sponsored, "Gilead Sciences" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored and "Children's Oncology Group" with 19 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente - Sacramento" #1 collaborator was "National Cancer Institute (NCI)" with 103 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "Canadian Cancer Trials Group" with 8 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente - Sacramento" are "Breast Cancer" (24 trials), "HIV Infections" (15 trials), "Colorectal Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Kaiser Permanente - Sacramento" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente - Sacramento" are "Drug" (182 trials), "Other" (94 trials), "Biological" (72 trials), "Procedure" (38 trials) and "Radiation" (30 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (31 trials), "Paclitaxel" (22 trials), "Placebo" (22 trials) and "Carboplatin" (19 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente - Sacramento" are 184 trials for "All" genders, 43 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente - Sacramento". undefined are not yet recruiting, 16 are recruiting, 83 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 115 completed trials in Kaiser Permanente - Sacramento, 3 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente - Sacramento, 6 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 144 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".